FOSL2 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BQO
|
MA0478.1
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 8 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR242EWU
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 3 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR103UVU
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 5 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR111ZXV
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
1 h with 100 nM Dexamethasone (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR330IJE
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 6 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR535HFQ
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 7 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR900RUE
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 4 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR686HIU
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 30 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR775UFR
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 12 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR067XTW
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 2 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR274WRI
|
MA0478.1
...
|
FOSL2 |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0478.1
...
|
FOSL2 |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0478.1
...
|
FOSL2 |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0478.1
...
|
FOSL2 |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0478.1
...
|
FOSL2 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0478.1
...
|
FOSL2 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0478.1
...
|
FOSL2 |
hFOB 1.19 (fetal osteoblast) |
DIFF |
Permissive
Robust
|
Homo sapiens |
GSE82295
|
MA0478.1
|
FOSL2 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BHP
|
MA0478.1
|
FOSL2 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUI
|
MA0478.1
|
FOSL2 |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BVB
|
MA0478.1
|
FOSL2 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR546KCN
|
MA0478.1
|
FOSL2 |
STHdhQ7 (striatal cells) |
|
Permissive
Robust
|
Mus musculus |
GSE43429
...
|
MA0478.1
...
|
FOSL2 |
STHdhQ111 (striatal cells) |
|
Permissive
Robust
|
Mus musculus |
GSE43429
...
|
MA0478.1
...
|
FOSL2 |
Th0-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0478.1
...
|
FOSL2 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0478.1
...
|
FOSL2 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0478.1
...
|
FOSL2 |
A549 (lung carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR593DGU
|
MA0478.1
...
|
FOSL2 |
LPS141 (Dedifferentiated liposarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE111253
...
|
MA0478.1
...
|
FOSL2 |
hESC-1 (Embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE69539
|
MA0478.1
|